Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | CRHBP | P24387 | 1/20 | 0.56 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | GAA | P10253 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.51 |
| ▸ | TUBB | P07437 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3529524 | 0.91 | MAPT (0.56) | MAPTKMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL597147 | 0.91 | MAPT (0.52) | MAPTKMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL3529521 | 0.91 | MAPT (0.56) | MAPTKMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL10787691 | 0.90 | RAB9A (0.55) | MAPTKMT2AMEN1ALDH1A1GAA | |
| SCHEMBL5522100 | 0.87 | MAPT (0.51) | MAPTKMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL5445350 | 0.84 | NPC1 (0.60) | MAPTKMT2AMEN1ALDH1A1GAA | |
| SCHEMBL5402602 | 0.83 | MAPT (0.55) | MAPTKMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL5402608 | 0.83 | MAPT (0.55) | MAPTKMT2AMEN1ALDH1A1GAA | |
| SCHEMBL21597816 | 0.83 | MAPT (0.58) | MAPTKMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL5521162 | 0.81 | MAPT (0.81) | MAPTKMT2AMEN1CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000004004-A1 | METHODS OF SYNTHESIZING SULTAMS AND ANTI-VIRAL COMPOSITIONS | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2000-01-27 | — | — | WO | claimed |
| CN-118510741-A | Method for removing t-butoxycarbonyl group | 中外制药株式会社 | 2024-08-16 | — | — | CN | disclosed |
| US-11643440-B2 | Peptide PAC1 antagonists | AMGEN INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20210395313-A1 | PEPTIDE PAC1 ANTAGONISTS | AMGEN INC. | 2021-12-23 | — | — | US | disclosed |
| EP-3630147-A2 | PEPTIDE PAC1 ANTAGONISTS | Amgen Inc. (US) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018222991-A2 | PEPTIDE PAC1 ANTAGONISTS | AMGEN INC. (US) | 2018-12-06 | — | — | WO | disclosed |
| US-8114606-B2 | Aldo-keto reductase specific immunoglobulin for use in diagnosis, classification and imaging of cell proliferative disorders | THE BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) | 2012-02-14 | — | — | US | disclosed |
| US-20110229909-A1 | RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-09-22 | — | — | US | disclosed |
| US-20110195411-A1 | ARL-1 SPECIFIC ANTIBODIES AND USES THEREOF | THE BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) | 2011-08-11 | — | — | US | disclosed |
| US-20100056441-A1 | Method for Inhibiting Angiogenesis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-03-04 | — | — | US | disclosed |
| WO-1999051624-A1 | REAGENTS AND METHODS FOR INHIBITING FURIN PROTEASE ACTIVITY | OREGON HEALTH SCIENCES UNIVERSITY (US) | 1999-10-14 | — | — | WO | disclosed |
| US-5939385-A | BIOADHESIVE POLYPEPTIDES FOR TISSUES WITH CROSSLINKABLE WITH TRANSGLUTAMINASE | ZYMOGENETICS, INC. (US) | 1999-08-17 | — | — | US | disclosed |
| US-5710244-A | Derivatized calcitonins | UNIVERSITY OF WASHINGTON | 1998-01-20 | — | — | US | disclosed |
| US-5698672-A | ADMINSTERING TO TREAT OSTEOPOROSIS, PAGET'S DISEASE AND HYPERPARATHYROIDISM | ZYMOGENETICS, INC. (US) | 1997-12-16 | — | — | US | disclosed |
| US-5698521-A | INHIBITING BONE RESORPTION | ZYMOGENETICS, INC. (US) | 1997-12-16 | — | — | US | disclosed |
| US-5601992-A | DETECTING INTERACTION BETWEEN PEPTIDE AND TARGET BY PLACING TARGET INTO CONTAINER, OVERLAYING WITH SUBSTRATE, APPLYING BEADS TO SUBSTRATE, EACH BEAD HAVING ASSOCIATED THEREWITH COPIES OF A SINGLE PEPTIDE, ALLOWING DIFFUSION, REACTION | BUNSEN RUSH LABORATORIES, INC. (US) | 1997-02-11 | — | — | US | disclosed |
| WO-1996031536-A1 | SYNTHETIC CALCITONIN MIMETICS | ZYMOGENETICS, INC. (US) | 1996-10-10 | — | — | WO | disclosed |
| WO-1995018152-A1 | DERIVATIZED CALCITONINS | ZYMOGENETICS, INC. (US) | 1995-07-06 | — | — | WO | disclosed |
| US-5428014-A | Tissue sealants; wound healing agents; medical equipment; biocompatible | ZYMOGENETICS, INC. (US) | 1995-06-27 | — | — | US | disclosed |
| WO-1995005396-A1 | TRANSGLUTAMINASE CROSS-LINKABLE POLYPEPTIDES AND METHODS RELATING THERETO | ZYMOGENETICS, INC. (US) | 1995-02-23 | — | — | WO | disclosed |